- CA$180.24m
- CA$238.84m
- CA$156.85m
- 38
- 96
- 71
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 69.2 | 39 | 102 | 200 | 157 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 66.5 | 115 | -6.54 | 105 | 119 |
Operating Profit | 2.69 | -76.2 | 109 | 94.7 | 37.4 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.004 | -82.3 | 91.1 | 85.6 | 34 |
Provision for Income Taxes | |||||
Net Income After Taxes | -26.8 | -113 | 115 | 83.9 | 32.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -26.8 | -113 | 115 | 83.9 | 32.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -26.8 | -113 | 115 | 83.9 | 32.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.386 | -1.02 | 0.874 | 0.924 | 0.361 |
Dividends per Share |